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ABSTRACT: The first phytochemical investigation of the stem extract of Millettia extensa 
resulted in the isolation and identification of six new isoflavones, millexatins A-F (1-6) 
together with 16 known compounds. The structures of these new compounds were 
determined on the basis of their spectroscopic data. Millexatin A (1) is a rare isoflavone 
containing three isoprenyl units on a modified A ring. Compounds 1, 6, 10, 11, and 14 
displayed promising antibacterial activity with MIC values of 2-8 µg/mL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 
 
The genus Millettia belongs to the family Leguminoseae, which is well known to produce 
flavonoids, chalcones, rotenoids and isoflavonoids.
1-4
 These types of compounds have been 
recognized to have cytotoxic,
3-6
 antimalarial,
7-9
 and antiinflamatory
5,10,11
 activities. Some 
species of Millettia have been utilized as traditional medicines to treat various diseases 
including dysmenorrhea, rheumatic pain, paralysis, snakebites, insect bites and 
inflammation.
12-14
 Millettia extensa (Benth.) Baker is a large climbing shrub that is 
distributed mainly in the northern part of Thailand. According to the information from the 
SciFinder Scholar database (Chemical Abstracts Service, Columbus, OH, USA), no 
phytochemical investigation or biological evaluation of this plant has been reported and its 
crude acetone extract showed good antibacterial activities. This information led us to 
investigate antibacterial compounds from this plant. Six new isoflavonoids (1-6) together 
with 16 known compounds and antibacterial activities of some isolated compounds are 
described in this paper. 
RESULTS AND DISCUSSION 
The extract of the stems of M. extensa was subjected to purification by repeated 
column chromatography which led to the isolation and elucidation of 19 isoflavones (1-19), 
two rotenoids (20 and 21), and a pterocarpan (22). By comparing their physical and 
spectroscopic data with published values, known compounds (7-22) were identified as 3'-
methylorobol (7),
15
 7,4'-di-O-prenylgenistein (8),
16,17
 5-hydroxy-7-methoxy-4'-O-(3-
methylbut-2-enyl)isoflavone (9),
18
 auriculatin (10),
19,20
 scandenone (11),
21,22
 5-O-methyl-4'-
O-(3-methyl-2-butenyl)alpinumisoflavone (12),
23
 elongatin (13),
24
 auriculasin (14),
20,21
 2'-O-
methylisoauriculatin (15),
22
 4'-methylalpinumisofiauone (16),
25
 2'-deoxyisoauriculatin (17),
22
 
isoauriculasin (18),
20
 isoauriculatin (19),
20,26
 (‒)-sumatrol (20),19 (‒)-6a,12a-dehydrotoxicarol 
(21)
27
 and (‒)-maackiain (22).28  
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Millexatin A (1) exhibited an ion peak at m/z 491.2447 ([M + H]
+
, calcd 491.2434) in 
its HRESITOFMS data, which indicated a molecular formula of C30H34O6. Analysis of the 
NMR spectroscopic data of 1 indicated it is related in structure to isoxantholupon
29
 which 
was contained a modified A ring. The major difference between of these two compounds 
found was that the core structure of isoxantholupon is a flavanone while that in compound 1 
is an isoflavanone. Compound 1 showed 
1
H NMR resonances for a H-bonded hydroxy 
proton, an olefinic proton, characteristic of isoflavanones, spin coupled ABC-type aromatic 
protons, an isoprenyl unit, and a germinal diisoprenyl group (Table 1). The germinal 
diisoprenyl unit was placed at C-8 due to the HMBC correlations (Figure 1) of H-1′′′/H-1′′′′ 
(δH 2.90 and 2.65) with C-7 (δC 194.6), C-8 (δC 57.0), and C-9 (δC 174.6), whereas the 
isoprenyl group was placed at C-6 from of the HMBC correlation of H-1′′ (δH 3.11) with and 
C-5 (δC 162.7), C-6 (δC 116.1) and C-7 (δC 194.6). It should be noted that griffonianone C
30
 
is the first example of an isoflavone with a modified A ring and was isolated from M. 
griffoniana by Yankep et al. in 2001. However, millexatin A is a rare isoflavone containing 
three isoprenyl units on a modified A ring.  
Millexatin B (2) molecular formula C26H26O6 was determined from its 
HRESITOFMS data ([M + H]
+ 
m/z 435.1804, calcd 435.1808).  The NMR spectroscopic data 
(Table 1) displayed characteristic resonances for a tetraoxygenated isoflavone similar to 
those of isoauriculatin
22
 isolated from the leaf extract of Millettia auriculata. The major 
distinction was the replacement of a H-bonded hydroxy group at C-5 in isoauriculatin
22
 with 
a methoxy group in 2. The HMBC correlation between the methoxy protons (δH 3.93) and the 
olefinic proton H-1′′ (δH 6.78) with C-5 (δC 155.0) further verified this deduction.         
Millexatin C (3) was deduced a molecular formula C28H30O7 from its HRESITOFMS 
data ([M + H]
+
 m/z 479.2055, calcd 479.2070). Analysis of the NMR spectroscopic data of 3 
(Tables 1 and 2) revealed that it is structurally related to millexatin B (2). The major 
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difference between these two compounds was found on ring B. Compound 2 showed 
resonances for an ABC-type aromatic proton, while compound 3 exhibited signals for two 
singlet para-aromatic protons at δH 6.64 and δH 6.92 and for an additional methoxy group at 
δH 3.75. These resonances were assigned to H-3′, H-6′ and OMe-2′, respectively, which were 
further supported from the following NOESY cross peaks (Figure 1): OMe-5′ (δH 3.85) with 
H-6′ (δH 6.92) and OMe-2′ (δH 3.75) with H-3′ (δH 6.64).  
Millexatin D (4) had a molecular formula of C26H26O6 which was deduced from its 
HRESITOFMS data ([M + H]
+
 m/z 435.1804, calcd 435.1808). The NMR spectroscopic data 
of 4 were similar to those of 2, except for the absence of resonances for an isoprenyloxy unit 
and H-5′ in 4 (Tables 1 and 2). The 
1
H NMR spectrum of 4 showed resonances for a 1,1-
dimethylallyl group. This unit was attached at C-5′, most likely formed via the Claisen 
rearrangement of the isoprenyl unit of compound 2. The HMBC correlations also supported 
this assignment. 
Millexatin E (5) molecular formula C25H22O6 was deduced from its HRESITOFMS 
data ([M + H]
+ 
m/z 441.1332, calcd 441.1314).  The NMR spectroscopic data (Tables 1 and 
2) were similar to those of auriculatin (10), having a 1,2,4-trisubstituted B ring. However, 
compound 5 showed resonances for two pyran rings that were located at C-5/C-6. 
Correlations in the HMBC spectrum between H-1′′ (δH 6.62) and C-5 (δC 154.1), C-6 (δC 
107.5), C-7 (δC 152.7) and between H-1′′′ (δH 6.72) and C-7 (δC 152.7), C-8 (δC 101.4), C-9 
(δC 152.0) supported the location of these two pyran rings. 
Millexatin F (6) had a molecular formula of C25H24O6, which was determined from its 
HRESITOFMS data ([M + H]
+
 m/z 421.1660, calcd 421.1651). The NMR spectroscopic data 
(Tables 1 and 2) were very similar to those of millexatin E (5), except for the absence of 
resonances for a pyran ring at C-5/C-6. Compound 6 showed additional resonances for an 
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isoprenyl unit and a H-bonded hydroxy group (δH 12.56) at C-5. The HMBC spectrum 
showed correlations of OH-5 (δH 12.56) with C-5 (δC 158.8), C-6 (δC 113.6), and C-10 (δC 
104.9) and of H-1′′ (δH 3.37) with C-5 (δC 158.8), C-6 (δC 113.6) and C-7 (δC 158.1). Thus, 
the structure of 6 was elucidated as shown. This structure was found in the SciFinder Scholar 
database (Chemical Abstracts Service, Columbus, OH, USA), but no references were 
indicated for this compound, suggesting that it is new.  
Putative biogenetic pathways toward the generation of the isoflavones 1-6 are shown 
in Scheme 1. The intermediate 23.1 could be generated from isoflavones 23 (not isolated 
from this study) via prenylation at C-8. Futher prenylation at C-8 of intermediate 23.1 would 
give compound 1. Compound 6 could be also obtained from intermediate 23.1 via cyclization 
of the isoprenyl group at C-8 onto the OH-7 group. A second cyclization between the 
isoprenyl group at C-6 and OH-5 group of compound 6 would give compound 5. A 
regioselective methylation of the OH-5 followed by cyclization of the isoprenyl group at C-6 
with the OH-7 group would give intermediate 23.2. This upon selective O-prenylation at C-4′ 
would produce compound 2. Claisen rearrangement of 2 could generate compound 4.
31
 
Finally, oxidation of compound 2 at C-5′ followed by O-dimethylation would then give 
compound 3.       
Most of the isolated compounds obtained were evaluated for their antibacterial 
activity against three Gram-positive and two Gram-negative bacteria, as summarized in Table 
3. Compounds 1, 6, 10, 11, and 14 showed potent antibacterial activity against Gram-positive 
bacteria with MIC values ranging from 2-8 µg/mL. Compound 7 showed moderate activity 
against S. aureus with a MIC value of 32 µg/mL. All remaining compounds showed either 
weak (MIC 64−128 µg/mL) or no perceptible antibacterial activity against all tested bacterial 
strains. 
EXPERIMENTAL SECTION 
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General Experimental Procedures. The general information of instruments and 
materials were the same as previous reports.
32-35
  
Plant Material. The stems of M. extensa were obtained in January 2017 from 
Donmoon Village, Silaphet Sub-district, Pua District, Nan Province, Thailand. Plant 
authentication was verified by Mr. Martin Van de Bult and a voucher specimen (MFU-
NPR0165) was deposited at the Natural Products Research Laboratory of Mae Fah Luang 
University.  
Extraction and Isolation. The chopped and dried stems of M. extensa (1.2 kg) were 
extracted with acetone (6 L) at room temperature (3 days × 2) and concentrated under 
reduced pressure to give an acetone extract (194.0 g). The crude extract (76.8 g) was 
subjected to QCC over silica gel, eluting with 100% hexanes to 100% acetone, to give six 
fractions (F1-F6). Fractionation of F3 (1.08 g) by Sephadex LH-20 (8:2 MeOH-CH2Cl2) gave 
three subfractions (F3A–F3C). Purification of F3C (124.3 mg) by CC (1:9 EtOAc-hexanes) 
yielded compounds 8 (1.4 mg), 9 (1.5 mg), 16 (1.7 mg), 17 (22.0 mg), 18 (1.8 mg), and 19 
(4.5 mg). Purification of F4 (639.8 mg) by CC (1.5:8.5 EtOAc-hexanes) gave compounds 4 
(3.7 mg), 5 (1.8 mg), and 15 (2.7 mg). Fractionation of F5 (13.4 g) by Sephadex LH-20 (9:1 
MeOH-CH2Cl2) gave four subfractions (F5A-F5D). Separation of F5A (2.7 g) by CC (2:8 
acetone-hexanes) yielded compounds 1 (18.0 mg), 2 (2.3 mg), 3 (3.1 mg), and 12 (7.2 mg). 
Purification of F5C (8.4 g) by CC (2:8 EtOAc-hexanes) yielded compounds 10 (2.2 g), 11 
(1.3 g), 13 (25.9 mg), 14 (2.3 mg), 20 (15.2 mg), and 21 (2.5 mg). Compounds 6 (471.0 mg), 
7 (7.3 mg), and 22 (41.3 mg) were obtained from F5D (950.1 mg) by CC (0.2:9.8 MeOH-
CH2Cl2).  
Millexatin A (1): Yellow viscous oil; UV (MeOH) λmax (log ε) 203 (4.28), 269 (3.93), 
349 (3.22) nm; IR (neat) νmax 3373, 2967, 1669, 1621, 1547, 1447 cm
-1
; 
1
H and 
13
C NMR, 
see Tables 1 and 2; HRESITOFMS m/z 491.2447 [M + H]
+
 (calcd for C30H35O6, 491.2434). 
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Millexatin B (2): Yellow viscous oil; UV (MeOH) λmax (log ε) 203 (4.15), 225 (3.98), 
268 (4.07), 331 (3.38) nm; IR (neat) νmax 3382, 2924, 1607, 1582, 1467 cm
-1
; 
1
H and 
13
C 
NMR, see Tables 1 and 2; HRESITOFMS m/z 435.1804 [M + H]
+
 (calcd for C26H27O6, 
435.1808). 
Millexatin C (3): Yellow solid, mp 112-115 
o
C; UV (MeOH) λmax (log ε) 272 (4.33), 
335 (3.49) nm; IR (neat) νmax 2976, 1639, 1511, 1466 cm
-1
; 
1
H and 
13
C NMR, see Tables 1 
and 2; HRESITOFMS m/z 479.2055 [M + H]
+
 (calcd for C28H31O7, 429.2070). 
Millexatin D (4): Yellow viscous oil; UV (MeOH) λmax (log ε) 291 (4.23), 334 (3.63) 
nm; IR (neat) νmax 3335, 2973, 1608, 1467 cm
-1
; 
1
H and 
13
C NMR, see Tables 1 and 2; 
HRESITOFMS m/z 435.1804 [M + H]
+
 (calcd for C26H27O6, 435.1808). 
Millexatin E (5): Yellow viscous oil; UV (MeOH) λmax (log ε) 296 (4.20), 333 (3.46) 
nm; IR (neat) νmax 3338, 2976, 1615, 1570, 1366 cm
-1
; 
1
H and 
13
C NMR, see Tables 1 and 2; 
HRESITOFMS m/z 441.1332 [M + Na]
+
 (calcd for C25H22NaO6, 441.1314). 
Millexatin F (6): Yellow solid, mp 218-219 
o
C; UV (MeOH) λmax (log ε) 202 (4.07) 
272 (4.17), 359 (2.91) nm; IR (neat) νmax 3349, 2976, 1639, 1429 cm
-1
; 
1
H and 
13
C NMR, see 
Tables 1 and 2; HRESITOFMS m/z 421.1660 [M + H]
+
 (calcd for C25H25O6, 421.1651). 
Antibacterial Assay. All bacterial strains used in these experiments were obtained 
from the Microbiological Resources Center, Bangkok, Thailand. The antibacterial assay was 
determined as recommended by Clinical and Laboratory Standards Institute.
34,35 
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Figure 1. Selected HMBC correlations (
1
H→
13
C) of compounds 1-6. 
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Scheme 1. Plausible Biosynthetic Pathway for Compounds 1–6.  
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Table 1. 
1
H NMR (600 MHz) Spectroscopic Data of Millexatins A-F (1–6) in CDCl3 (δ in ppm, J in Hz) 
position 1
a
  2  3  4  5  6
a
  
2 8.12, s 7.89, s 7.80, s 7.87, s 7.81, s 7.96, s 
8 - 6.70, s 6.63, s 6.67, s - - 
3′ 6.59, d (2.0) 6.68, d (2.5) 6.64, s 6.58, s 6.54, d (2.5) 6.56, d (2.5) 
5′ 6.55, dd (8.5, 2.0) 6.65, dd (8.6, 2.5) - - 6.42, dd (8.3, 2.5) 6.48, dd (8.4, 2.5) 
6′ 7.01, d (8.5) 7.03, d (8.6) 6.92, s 6.93, s 6.94, d (8.3) 7.00, d (8.4) 
1′′ 3.11, d (7.0) 6.78, d (10) 6.76, d (10.0) 6.74, d (10.0) 6.62, d (10.0) 3.37, d (7.3) 
2′′ 5.08, t (7.0) 5.79, d (10) 5.74, d (10.0) 5.76, d (10.0) 5.65, d (10.0) 5.22, br t (7.3) 
4′′ 1.75, s 1.51, s 1.50, s 1.49, s 1.53, s 1.84, s 
5′′ 1.67, s 1.51, s 1.50, s 1.49, s 1.53, s 1.71, s 
1′′′ 2.90, dd (13.7, 7.0); 
2.65, dd (13.7, 7.0) 
4.54, d (7.0) 4.65, d (6.6) - 6.72, d (10.0) 6.71, d (10.0) 
2′′′ 4.68, t (7.0) 5.53, t (7.0) 5.55, t (6.6) 6.18, dd (17.6, 10.4) 5.65, d (10.0) 5.62, d (10.0) 
3′′′ - 
- 
- 
5.29, d (10.4); 
5.35, d (17.6) 
- - 
4′′′ 1.55, s 1.82, s 1.81, s 1.43, s 1.50, s 1.49, s 
5′′′ 1.51, s 1.77, s 1.79, s 1.43, s 1.50, s 1.49, s 
1′′′′ 2.90, dd (13.7, 7.0); 
2.65, dd (13.7, 7.0) 
- - - - - 
2′′′′ 4.68, t (7.0) - - - - - 
4′′′′ 1.55, s - - - - - 
5′′′′ 1.51, s - - - - - 
OH-5 12.43, s - - - - 12.56, s 
OMe-5 - 3.93, s 3.91, s 3.90, s - - 
OH-2′ 5.50, br s 9.34, s - 8.99, s 9.44, br s 8.50, s 
OMe-2′ - - 3.75, s - - - 
OH-4′ 7.94, s  - 5.90, s 5.00, br s 5.09, s 
OMe-5′ - - 3.85, s - - - 
 
a 
Recorded on 400 MHz. 
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Table 2. 
13
C NMR (150 MHz) Spectroscopic Data of Millexatins A-F (1–6) in CDCl3 (δ in ppm) 
position 1
a
 2 3
 
 4
 
 5
 
 6
 a
 
2 154.1 152.0 151.9 152.4 151.8 154.4 
3 129.0 125.0 122.0 125.3 124.9 123.0 
4 179.6 178.0 174.4 177.8 178.4 182.0 
5 162.7 155.0 155.2 155.1 154.1 158.8 
6 116.1 113.6 112.8 113.5 107.5 113.6 
7 194.6 158.6 157.4 158.5 152.7 158.1 
8 57.0 99.9 99.5 99.9 101.4 100.6 
9 174.6 157.9 158.2 158.0 152.0 150.3 
10 114.4 111.4 112.7 111.6 107.7 104.9 
1′ 110.8 113.5 111.8 113.1 113.2 112.6 
2′ 159.1 157.3 151.2 156.1 157.5 157.1 
3′ 106.7 104.3 100.2 107.7 105.6 106.3 
4′ 157.6 160.5 148.4 156.4 157.3 158.2 
5′ 109.1 107.8 143.0 124.6 107.4 108.6 
6′ 130.9 130.3 115.1 127.2 130.3 130.5 
1′′ 21.0 115.0 115.7 115.3 115.1 21.3 
2′′ 121.5 130.0 130.2 130.7 128.2 121.6 
3′′ 131.9 77.6 77.2 76.9 77.7 131.9 
4′′ 17.9 27.9 27.8 27.9 27.8 17.7 
5′′ 25.8 27.9 27.8 27.9 27.8 25.7 
1′′′ 38.8 64.4 65.6 39.2 114.5 114.6 
2′′′ 116.7 119.0 119.6 147.4 127.2 127.2 
3′′′ 136.0 138.0 137.2 113.1 78.0 78.3 
4′′′ 25.7 25.4 25.4 26.7 27.3 28.0 
5′′′ 17.8 17.7 17.8 26.7 27.3 28.0 
1′′′′ 38.8 - - - - - 
2′′′′ 116.7 - - - - - 
3′′′′ 136.0 - - - - - 
4′′′′ 25.7 - - - - - 
5′′′′ 17.8 - - - - - 
OMe-5 - 62.5 62.3 62.6 - - 
OMe-2′ - - 56.2 - - - 
OMe-5′ - - 56.1 - - - 
       
           a 
Recorded on 100 MHz.   
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Table 3. Antibacterial Activity of Compounds 1, 6-7, 10-11, 13-14, 17, 19-20, and 22 
compound 
MIC (µg/mL) 
Gram-positive bacteria  Gram-negative bacteria 
S. aureus  
TISTR 1466 
S. epidermidis 
ATCC 12228 
B. subtilis  
TISTR 008 
 S.typhimurium 
TISTR781 
Ps. aeruginosa 
TISTR 292 
1 2 2 2  128 128 
6 2 2 2  128 128 
7 32 64 64  128 128 
10 2 2 2  128 128 
11 2 4 2  128 128 
13 inactive inactive inactive  128 128 
14 4 4 8  128 128 
17 inactive inactive inactive  128 128 
19 inactive inactive inactive  128 128 
20 inactive inactive inactive  128 128 
22 inactive inactive inactive  128 128 
vancomycin 0.25 0.25 0.25  Not tested Not tested 
gentamycin Not tested Not tested Not tested  0.25 2 
a
Inactive at >128 µg/mL. 
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